Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Andaman7 is a Belgian-American digital health company that offers a mobile personal health record and a peer-to-peer health data exchange platform for patients, healthcare providers, and life science organizations. Its core product enables patients to collect, store, and share medical data from hospitals, labs, devices, and caregivers while maintaining patient control and privacy. The company also markets its platform to pharmaceutical, medical device, and research organizations for decentralized clinical trials, electronic patient-reported outcomes, real-world evidence collection, eConsent, and post-market studies. Andaman7 emphasizes interoperability and compliance, including FHIR, LOINC, SNOMED, GDPR, HIPAA, GCP, FDA 21 CFR Part 11, and EU Annex 11. The business appears to be a commercial health technology platform company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Andaman7.